The International Diabetes Federation is seeking the nomination of members for its Board of Directors 2020-2021.

The elections will be held at the IDF General Assembly in Busan, Korea, on 2 December 2019.

Nominations are required for the following positions:

  • President-Elect - 1 vacancy
  • Vice-Presidents without portfolio - 6 vacancies (2 physicians, 2 healthcare professionals, 2 lay persons)
  • Vice-President Finance - 1 vacancy
  • Vice-President Strategic Governance - 1 vacancy
  • Members of the Nominating Committee - 4 vacancies

Overarching criteria applicable to all categories:

  • All candidates must demonstrate a well-established interest in diabetes at a professional and/or a personal level, with solid evidence of sustained engagement with diabetes activism in their country.
  • All candidates must be able to demonstrate the ability and commitment to make time available for their Board duties. The terms of reference should clarify that this would require at least three full week-ends per year and at least 3 days per month for participation in virtual meetings and the review and preparation of materials. In addition, the candidate should confirm access to adequate broadband coverage in their home or workplace to take part in virtual meetings.
  • All candidates must demonstrate a reasonable level of international engagement in diabetes, within a well-established international organisation or network.

Skill Sets - for all nominees and for each category

General skills

In addition to the overarching criteria, candidates wishing to be nominated for any of the categories should provide evidence of skills in one or more of the following areas:

  • Advocacy - direct engagement in national diabetes advocacy campaigns.
  • Communications - paper or web-based publishing
  • Research - active engagement in academic research published in high impact international journals.
  • Teaching - active engagement in professional and tertiary (post-secondary) education in the past 5-10 years.
  • Ethics - active engagement in ethics and professional conduct committees for practice in the business, medical or non-medical domain or medical or social care research through management of submissions or service on review panels.

Such skills may be professional or developed through volunteer work in diabetes. Such skills should have been exercised at a high level of national or international engagement.

Medical & Scientific skills

Candidates wishing to nominate for the Vice-President without portfolio in the Physician or Healthcare Professional category must demonstrate at least 10 years of direct engagement in diabetes care, research and education, with a significant proportion of that engagement having taken place in the past 5 years.

Financial management skills

Candidates wishing to nominate for the Vice-President Finance category must provide evidence that they have professional accounting qualifications and developed skills in financial management, possibly through high-level corporate employment.

Governance skills

Candidates wishing to nominate for the Vice-President Strategic Governance category must provide evidence that they have professional qualifications and developed skills in governance, ideally with a professional qualification in law or well-established skills in corporate governance and the legal requirements for the management of not-for-profit organisations.

Language

All candidates must be able to communicate in English.

How to apply

A person may be nominated for more than one position, but can only be elected to one position. Please note, however, that candidates can only stand for one position as Vice-President (with or without portfolio).

The Nominating Committee welcomes nominations from anyone interested in shaping the future of the Federation.

Each candidate must submit an application form with all required documents to the IDF Secretary, This email address is being protected from spambots. You need JavaScript enabled to view it.. Nominations received through other channels will not be taken into consideration. 

The Nominating Committee requires the following information for each candidate:

    • Name and contact details
    • The position(s) for which the person wishes to be nominated
    • A short motivational statement/letter
    • The completed application form
    • A recent Curriculum Vitae (CV)
    • A recent photograph

How to nominate a candidate

Self-nomination is not permitted.

All candidates must be recommended by:

  • At least five IDF Members in the case of President-Elect
  • At least three IDF Members for all other positions

Please contact This email address is being protected from spambots. You need JavaScript enabled to view it. to receive the nomination and/or application form.

The deadline to submit nominations and applications is 18 July 2019.

IDF logoThe hummingbird logo of the International Diabetes Federation has its origins in the Dutch Diabetes Association, an organization for people with diabetes founded in 1945.

Known as “the bird of hope”, a hummingbird was chosen by the Dutch Diabetes Association as it symbolised the optimism of people with diabetes as they found ways to manage their condition, overcome its challenges and deal with its potentially devastating complications.

In 1980, the hummingbird became the official symbol of the International Diabetes Federation. The logo has since represented and united millions of people throughout the world with a message of hope in the fight against diabetes.

The logo of the International Diabetes Federation (IDF) is a registered trademark and its use adheres to strict terms and conditions.

For more information regarding the use of the logo, please contact This email address is being protected from spambots. You need JavaScript enabled to view it..

The blue circle

Blue circleThe blue circle is the universal symbol for diabetes. It was introduced in 2006 to give diabetes a common identity. The symbol aims to:

  • Support all existing efforts to raise awareness about diabetes
  • Inspire new activities, bring diabetes to the attention of the general public
  • Brand diabetes
  • Provide a means to show support for the fight against diabetes

History

The blue circle icon was originally developed for the campaign that resulted in the passage of United Nations Resolution 61/225 "World Diabetes Day."

The campaign for a United Nations Resolution on diabetes was a response to the diabetes pandemic that is set to overwhelm healthcare resources everywhere. The campaign mobilised diabetes stakeholders behind the common cause of securing a United Nations Resolution on diabetes. The United Nations passed Resolution 61/225 ‘World Diabetes Day’ on December 20 2006.

Why a circle?

The circle occurs frequently in nature and has thus been widely employed since the dawn of humankind. The significance is overwhelmingly positive. Across cultures, the circle can symbolize life and health. Most significantly for the campaign, the circle symbolizes unity. Our combined strength is the key element that made this campaign so special. The global diabetes community came together to support a United Nations Resolution on diabetes and needs to remain united to make a difference. As we all know: to do nothing is no longer an option.

Why blue?

The blue border of the circle reflects the colour of the sky and the flag of the United Nations. The United Nations is in itself a symbol of unity amongst nations and is the only organization that can signal to governments everywhere that it is time to fight diabetes and reverse the global trends that will impede economic development and cause so much suffering and premature death.

Promote the symbol

IDF encourages everyone to use the blue circle as a reference to diabetes and the millions of people affected by the disease. We welcome the use of the logo in publications: magazines, video, online information, etc.

The symbol may not be used without prior permission by IDF. To request use of the symbol, please complete our online form.

Before requesting use of the symbol, please read our blue circle usage guidelines.

I. GENERAL FRAMEWORK

The AISBL International Diabetes Federation, whose registered office is located at 1170 Brussels, Chaussée de la Hulpe 166 C3, is registered with the Crossroads Bank for Enterprises under number 0433.674.528. The association is an international center of competence for diabetes.

In accordance with the General Data Protection Regulation (GDPR), when the IDF processes personal data of any kind, it shall do everything in its power to preserve their confidentiality and to inform the data subjects, in the greatest transparency, of the reasons for and means of the processing it undertakes.

In the course of its activities, the IDF may collect, store and process personal data concerning you, if you:

    • Are a contact person of one of our business partners, such as suppliers, consultants, etc.;
    • Are a contact person of one of our members;
    • Participate or speak at our congresses or events;
    • Participate to our survey’s;
    • Subscribe to a newsletter;
    • Download the World Diabetes Day App and submit a picture through it;
    • Are a visitor to our website and online platforms;
    • Download an IDF resource or material;
    • Submit an image or information about an activity on our online platforms;
    • Request to use or reproduce an IDF resource.

Providing personal information is up to you. If you do not want your personal information collected, please do not submit it. If you choose not to give personal information to us, we may not be able to provide you with access to some of the pages and resources or other features and services on this Site and the Other Platforms.

Occasionally, we may ask you for personal information about other people - for example, your family or other authorised representatives. If you give us this information, we rely on you to tell those people that you are giving their personal information to us and to make them aware of this Privacy Policy.

In this Privacy Policy, you will find additional information about the processing of your personal data and your possible rights.

IDF may modify this Privacy Policy at any time. Only the version published on this website — www.idf.org — is applicable.

For any other questions regarding the processing of your personal data, please contact:

International Diabetes Federation
GDPR Officer
Chaussée de La Hulpe 166
1170 Brussels
Belgium
This email address is being protected from spambots. You need JavaScript enabled to view it.
+3225385511

II. WHO ARE YOU AND WHAT DO WE DO WITH YOUR DATA?

1. YOU ARE A BUSINESS PARTNER (OR A CONTACT PERSON OF ONE OF OUR BUSINESS PARTNERS)

Why do we use your data?

We use your personal data as part of our contractual relationship (or in the preparatory stages), as well as for development of our activities.

What is the legal basis for processing your data?

The processing of your personal data is carried out for the purpose of fulfilling our contractual obligations (or during the preparatory stages for this purpose).

If you receive our newsletters and invitations to our activities, it is because you have given your consent.

What data do we collect and how did we obtain your data?

Your data or part of it has been provided to us by your employer or comes from publicly available sources. We collect the following categories of data:

  • identity data (surname, first name, title, position, etc.);
  • contact data (your company, company postal address, business e-mail address, business telephone number, etc.);
  • invoicing data etc.

How long do we keep your data?

In principle, we keep your personal data for as long as the contractual relationship lasts and as long as it remains relevant.

However, it is possible that we may be required by law to retain your data for a longer period of time or that we may have to retain it in connection with ongoing litigation.

It is possible that after the end of our contractual relationship, you may continue to receive information from us for marketing purposes. As explained below, you may withdraw your consent at any time.

2. YOU ARE A CONTACT PERSON AT ONE OF OUR MEMBERS

Why do we use your data?

We use your personal data only for the purposes of the coordination and communication of our activities with your member-organisation.

What is the legal basis for processing your data?

The processing of your personal data is carried out for the purpose of fulfilling our mission.

What data do we collect and how did we obtain your data?

Your data or part of it has been provided to us by the member-association for which you act as a contact person or comes from publicly available sources.

We collect the following categories of data:

  • identity data (surname, first name, title, position, etc.);
  • contact data (postal address of the member-association, business e-mail address, business telephone number, etc.);

How long do we keep your data?

In principle, we keep your personal data for as long as it remains relevant and up to date. If you no longer act as a contact person, we will no longer use your personal data.

3. YOU PARTICIPATE OR SPEAK AT OUR CONGRESSES OR EVENTS

Why do we use your data?

We use your personal data for the purposes related to the organisation of our congress or event, for example, registration, invoicing, catering, hotel arrangements, visa, etc.

As a participant or speaker at our events, you have shown particular interest in our organisation. Therefore, we will include your contact details in our mailing list for our newsletters, invitations for events and/or survey’s.

What is the legal basis for processing your data?

The processing of your personal data is carried out based upon your consent. If you decide to participate or if you accept to speak at our congresses and events, you consent with the processing of your personal data for the purposes related to these events.

What data do we collect and how did we obtain your data?

Depending on the type of event and on your status as a participant or speaker, we might collect the following categories of data:

  • identity data (surname, first name, title, position, nationality, etc.);
  • contact data (postal address, e-mail address, telephone number, etc.);
  • invoicing information;
  • diabetes related information;
  • sponsorship ethical code;
  • affiliation;

Pictures will be taken during the event. These pictures will be used by IDF alone and will be accessible to the participants of the event. Only pictures of overall views will be included on public platforms such as the IDF website, newsletters and social media. If you wish to remove a picture of yourself, you can always contact IDF.

How long do we keep your data?

In principle, we keep your personal data for as long as it remains relevant and up to date. As explained below, you can withdraw your consent at any time and we will delete the personal data which is related to you.

4. YOU PARTICIPATED IN A SURVEY

Why do we use your data?

We use your personal data as part of our research activities.

What is the legal basis for processing your data?

The processing of your personal data is carried out based upon your consent.

What data do we collect and how did we obtain your data?

The specific data we collect varies from survey to survey. We only process information that you provided to us through the survey.

How long do we keep your data?

In principle, we keep your personal data to perform and analyze the survey. We will keep the results of the survey during 5 years. Following this period, the information will be anonymized.

5. YOU SUBSCRIBED TO A NEWSLETTER

Why do we use your data?

We use your personal data to keep you informed about our activities and to involve you in our missions.

What is the legal basis for processing your data?

The processing of your personal data is carried out based upon your consent.

What data do we collect and how did we obtain your data?

We only process information that we have received from you directly by filling out the fields in the relevant subscription form.

You may also be included in our mailing lists, because you have shown particular interest in our activities by downloading resources from our website, by participating to our events or survey’s, or by reaching out to us in any other way. We collect the following categories of data:

  • identity data (surname, first name, language, nationality, gender etc.);
  • contact data (email address);

How long do we keep your data?

In principle, we keep your personal data as long as it remains up to date and relevant.

6. YOU DOWNLOADED THE WORLD DIABETES DAY APP AND SUBMITTED A PICTURE THROUGH IT

Why do we use your data?

We use your personal data to help promote awareness of the blue circle, the global symbol for diabetes.

What is the legal basis for processing your data?

The processing of your personal data is carried out based upon your consent.

What data do we collect and how did we obtain your data?

We only process information that we have received from you directly by filling out the fields in the relevant image sharing form. We collect the following category of data:

  • Identity data (surname, first name, country)

How long do we keep your data?

In principle, we keep your personal data for as long as it remains relevant and up to date.

7. YOU ARE A VISITOR TO OUR WEBSITE

The International Diabetes Federation (IDF) administers this Site and the following online platforms and applications:

  • www.diabetesatlas.org
  • www.worlddiabetesday.org
  • www.idfdiabeteschool.org
  • www.diabetesvoice.org
  • d-net.idf.org
  • www.lifeforachild.org
  • discoverdiabetes.idf.org
  • kids.idf.org
  • World Diabetes Day app
  • KiDS app

The material provided within this Site and the other Platforms is intended for educational and informational purposes only. It is provided with the understanding that IDF is not engaged in rendering medical service or recommendation. None of the information contained within this Site and the Other Platforms is intended to replace consultations with qualified healthcare professionals and should therefore not be relied upon to do so.

References and links contained within this Site and the Other Platforms to products, services, businesses, organizations, websites and events which are not under the control of the International Diabetes Federation (collectively, ‘Referenced Information’) should not be construed as endorsements by IDF. Referenced Information is provided for convenience of reference only and its provision is not intended as a warranty of any type regarding the Referenced Information or any information referenced at any such website.

Referenced Information within this Site and the Other Platforms is for informational purposes only. It is not intended as medical advice, and should not be relied upon as a substitute for consultations with qualified health professionals.

Any reviews, opinions, and recommendations contained within this site and the Other Platforms are not necessarily those of IDF or endorsed by IDF. IDF cannot be held responsible for any damages resulting from the use of any Referenced Information or the inclusion of any Referenced Information within the site and the Other Platforms.

Why do we use your data? We may use your personal information as follows:

  • To respond to your questions and requests, to provide you with access to certain areas and features and to communicate with you about your activities on this website.
  • To share it with our Related Parties as required to perform functions on our behalf in connection with the Site (such as administration of the website or other features on it, data analysis or customer services etc.). To do so, it may be necessary for us to transmit your personal information outside the Jurisdiction below and you agree to this transfer. Further use or disclosure of the information by our Related Parties for other purposes is not permitted.
  • To provide you with information from us or our Related Parties.
  • For other purposes set out when your information is collected or in any additional terms and conditions applicable to the particular feature of the Site or the Other Platforms.
  • For disclosures required by law, regulation or court order.
  • For the purpose of or in connection with legal proceedings or necessary for establishing, defending or exercising legal rights.
  • In an emergency to protect the health or safety of Site users or the general public or in the interests of national security.

Except as provided herein, we will not provide any of your personal information to any third parties without your specific consent.

What is the legal basis for processing your data?

When you visit our website, you agree to the processing of your data for the purposes mentioned above. We will only process your data in the context of our legitimate interests, in order to inform you about our missions or to improve them.

What data do we collect and how did we obtain your data?

The International Diabetes Federation (IDF) collects personal information about you (i.e. information which may identify you in some way, such as your name, address, age, other contact details such as telephone number, email address etc. and passwords) through this Site and the Other Platforms only when you voluntarily submit it. This may occur when you:

  • Subscribe to a newsletter
  • Request information, complete a survey or other feature of the website
  • Download a resource
  • Purchase a publication or merchandise item
  • Request to use or reproduce an IDF resource
  • Download the World Diabetes Day app and submit a picture through it

How long do we keep your data?

Your personal data will be kept as long as they are relevant for the purposes of the processing mentioned below. In general, the information you complete on our contact forms or online tools is not stored for more than 5 years.

Use of cookies and statistical analysis of website usage

When you connect to this Site or the Other Platforms we may use "cookie" technology and IP addresses to automatically collect certain technical non-personally identifiable information. This may include:

  • Type of Internet Browser or computer
  • Domain name of your Internet Service Provider
  • Number of page visits and the character and duration of such visits.
  • We also track the number of visitors to our website in an aggregate form. Personally identifiable information is not extracted during this process.
  • We also analyse the usage of our website and other online platforms through the “Google Analytics” tool. This tool only provides us with anonymous data.

This information helps us keep our Site and the Other Platforms fresh and interesting to our visitors and tailor content to their interests.

We may disclose certain non-personally identifiable information to potential partners, or other third parties, but we will not disclose any personally identifiable information, except as provided in this Policy.

You may set your computer browser to disable cookies or to alert you when cookies are being sent. If you disable cookies, we may be unable to optimise your visit to our Site and the Other Platforms and certain features may not be available.

III. SHARING OF PERSONAL DATA

The personal data processed by IDF are accessible to staff members on a "need to know" basis, in the context of the performance of their work.

IDF may share certain personal data with Partners and Member Organisations.

In addition, IDF uses third party service providers for various purposes in carrying out its activities, in particular with regard to:

    • the provision of IT platforms, operating systems, etc...;
    • the execution of specific tasks requiring particular expertise.

IDF only cooperates with service providers who comply with the legislation on the processing of personal data. Your personal data will not be resold by IDF or transmitted to third parties for commercial use.

IV. YOUR RIGHTS

This Site and the Other Platforms are controlled and operated from Brussels, Belgium (regardless of where hosting servers are located). All matters relating to this Site are governed by the laws of the above Jurisdiction, without reference to conflict or choice of law principles.

You agree that jurisdiction and venue for any legal proceeding relating to the Site shall be in appropriate courts located in the above Jurisdiction. We do not warrant or imply that the Site and the Other Platforms or materials on them are appropriate for use outside of the above Country. The information set forth in this Site and the Other Platforms concerning any products or services is applicable only in the Jurisdiction, and these products or services may not be available in all locations. If you are located outside of this Country, you are solely responsible for compliance with any applicable local laws.

You have the right to access and rectify the personal data that IDF processes about you at any time.

Within the limits of what is provided by law, you have the right to have your personal data deleted, to request that the processing be limited and to oppose the processing of your personal data. You may withdraw your consent at any time for certain processing operations involving your personal data.

In addition, you are also entitled to the portability of your personal data, provided that the legal conditions are met.

You may exercise these rights by contacting IDF using the contact details mentioned in TITLE I of the Privacy Policy.

You also have the right to complain to the supervisory authority:

Data Protection Authority
Rue de la Presse, 35
1000 Brussels
Belgium
This email address is being protected from spambots. You need JavaScript enabled to view it.
Tel: +32(0)2 274 48 00
www.autoriteprotectiondonnees.be

V. DATA SECURITY

IDF takes all reasonable measures to prevent the loss, misuse, disclosure, unauthorized access or alteration of personal data.

The necessary technical and organizational measures shall be taken to ensure an adequate level of safety.

VI. AUTOMATED INDIVIDUAL DECISION

The processing of personal data by IDF does not give rise to any automated decision.

The International Diabetes Federation (IDF) has updated its privacy policy to comply with the new European Union General Data Protection Regulation (GDPR), which came into effect on May 25, 2018. View the privacy policy here.

La FID he actualizado su política de privacidad para cumplir con los nuevos requisitos del Reglamento General de Protección de Datos de la Unión Europea (RGPD). Puede verlo aquí

La FID à mis à jour sa politique de confidentialité afin de nous conformer aux nouvelles exigences de la nouvelle Règlementation Européenne sur la Protection des Données (RGPD). Vous la retrouverez ici.

If you wish your personal data to be completely removed from the IDF contact database, please provide your email below.

Si desea que retiremos sus datos completamente de nuestra base de datos, por favor complete el formulario abajo.

Si vous souhaitez que vos données personnelles soient complètement supprimées de notre base de données, veuillez compléter le formulaire ci-dessous.



If you have any questions related to the protection of personal data provided to IDF, please contact This email address is being protected from spambots. You need JavaScript enabled to view it..

Si tiene alguna pregunta referente a la protección personal de datos contacte con This email address is being protected from spambots. You need JavaScript enabled to view it..

Si vous avez des questions concernant la protection de vos données, n’hésitez pas à vous adresser à This email address is being protected from spambots. You need JavaScript enabled to view it..

1950

  • The International Diabetes Federation is officially founded on September 23, 1950 in Amsterdam.
  • An Executive Board is constituted, consisting of a President, three Vice Presidents, a Secretary-Treasurer and two Honorary Presidents. President: Dr. R.D. Lawrence
    (UK); Vice Presidents: Dr. J.P. Hoet (Belgium); Mr. Maurice Paz ( France); Dr. Howard Root (USA); Secretary-Treasurer: Dr. F. Gerritzen ( The Netherlands). Honorary
    Presidents: Prof. Charles Best (Canada); Prof. Elliot Joslin (USA).

1952 -1955

  • Dr. R.D. Lawrence is re-elected as President for a second term.
  • 1952: First IDF Congress held in Leiden, the Netherlands.
  • A sub-committee is formed to draft the first constitution, which is subsequently ratified by the 16 member associations of IDF.
  • IDF member countries include: Belgium, Denmark, Finland, France, Germany, Italy, Norway, The Netherlands, Portugal, Spain, Sweden, United Kingdom, Australia, Canada, Uruguay and the USA.

1955 – 1958

  • Dr. R.D. Lawrence is re-elected as President for a third term.
  • 1955: Second IDF Congress held in Cambridge, UK.
  • An Education Committee is created to organise Postgraduate courses.
  • A small committee is formed to collaborate with the World Health Organization (WHO) and its subsidiaries, and the World Medical Association.
  • 1957: IDF establishes offical relations with WHO.

1958 -1961

  • Prof. J.P. Hoet (Belgium) assumes the Presidency from Dr. R.D. Lawrence at the end of the meeting of the General Council — a practice that would become the norm.
  • 1958: Third IDF Congress held in Dusseldorf, Germany.
  • All new applicants for membership must be sponsored from two existing member associations.
  • French becomes the second official language of IDF.
  • It is decided that Presidents who serve their full terms will be appointed as Honorary Presidents. Prof. Bernardo Houssay from Argentina and R.D. Lawrence are elected the first Honorary Presidents.

1961-1964

  • Prof. Howard Root (U.S.A.) assumes the Presidency.
  • 1961: Fourth IDF Congress held in Geneva, Switzerland.
  • Member associations are appointed as Vice Presidents in place of individuals.

1964 - 1967

  • Prof. Howard Root is re-elected as President for a second term
  • 1964: Fifth IDF Congress is held in Toronto, Canada in 1964

1967 – 1970

  • Dr. Rachmiel Levine (U.S.A.) assumes the Presidency.
  • 1967: Sixth IDF Congress held in Stockholm, Sweden.
  • Individuals are once again elected as Vice Presidents but member associations remain on the Executive Board.
  • Disaffiliation of a member association is incorporated into the IDF Constitution.

1970-1973

  • Prof. Frank Young (UK) assumes the Presidency.
  • 1970: Seventh IDF Congress held in Buenos Aires, Argentina.
  • A WHO representative, Dr. Chopra, is invited as an Observer to the Executive Board, a sign of increasing collaboration between IDF and WHO.

1973 -1976

  • Prof. Rolf Luft (Sweden) assumes the Presidency.
  • 1973: Eighth IDF Congress held in Brussels, Belgium.
  • The Commission for Teaching Programme is initiated, providing a seven day refresher course on diabetes.
  • The Commission for Socio-Medical Programmes is established under Prof. G. Verdonk, to specifically look into programmes for lay people.
  • 1974: decision to revise the IDF constitution.

1976 - 1979

  • Prof. R. Luft is re-elected as President for a second term.
  • 1976: Ninth IDF Congress held in New Delhi, India.
  • The existing constitution is formally repealed and a new Constitution and By-laws are adopted unanimously by the General Council.
  • Prof. V. Foglia; Prof. F. Gerritzen; Dr. Alexander Marble; and Mr. Maurice Paz are elected as Honorary Presidents.
  • 1977: it is decided to take the IDF Congress to Africa and Nairobi, Kenya, is appointed as host city for the tenth IDF Congress in 1982.

1979 - 1982

  • Dr. Albert Renold (Switzerland) assumes the Presidency
  • 1979: Tenth IDF Congress held in Vienna, Austria
  • 1980: the hummingbird becomes the official logo of IDF
  • Member associations no longer sit on the Board as organisations.
  • Special Review Committee - chaired by Dr. Luft - set up to assess the activities and strategy of the Federation. Members included Drs. Bajaj, Pfeiffer, Krall and Mr. Decker.
  • In response to apartheid in South Africa, it is decided that henceforth all IDF Congresses can only be hosted in countries where all IDF Member Associations and nationals of that country are freely admitted and accepted as members.
  • Prof. R. Luft becomes the first Honorary Member of IDF.

1982 -1985

  • Prof. Leo Krall (U.S.A.) assumes the Presidency
  • 1982: 11th IDF Congress held in Nairobi, Kenya. IDF members from South Africa are not allowed to enter Kenya to attend due to apartheid laws.
  • The seven regions of IDF formally created
  • Board of Management created to oversee the day to day administration of the Federation.
  • Nominating Committee created
  • The IDF Secretariat becomes the “Executive Office” of the Federation

1985-1988

1988-1991

  • Prof. J. J. Hoet (Belgium) assumes the Presidency
  • 1988: 13th IDF Congress held in Sydney, Australia

1991-1994

  • Wendell Mayes Jr. (U.S.A.) becomes the first lay President of the Federation
  • 1991: 14th IDF Congress held in Washington DC, USA
  • 14 new associations are welcomed as full members.
  • World Health Assembly Resolution 42.35 results in the creation of a Diabetes Unit within WHO
  • World Diabetes Day initiated by IDF and WHO in 1991
  • Prof. J.J. Hoet and Prof. H. Keen are elected Honorary Presidents
  • The following Task Forces are established: Diabetes Health Economics; Finance and By-laws; Revenue Generation

1994 – 1997

  • Prof. Jak Jervell (Norway) assumes the Presidency
  • 1994: 15th IDF Congress held in Kobe, Japan
  • IDF membership increases to 130 national diabetes associations in 108 countries
  • Education Foundation created
  • Consultative sections on Childhood and Adolescent Diabetes and Diabetes Education established
  • The following Task Forces are established: Non-Insulin-dependent Diabetes Mellitus (NIDDM), Insulin, Appropriate Technology, Clinical Practice Guidelines, Member Association Development, Regional Development
  • Prof. Harold Rifkin and Prof. S. Baba are elected Honorary Presidents
  • Archibishop Trevor Huddleston is elected Honorary Member

1997-2000

  • Ms. Maria de Alva (Mexico) assumes the Presidency
  • 1997: 16th IDF Congress held in Helsinki, Finland
  • IDF/WHO working group established
  • 1999: The IDF Bulletin is renamed "Diabetes Voice" and published in English, French and Spanish
  • A By-Law is passed granting IDF fiscal and operational responsibility for its Congress
  • IDF website launched in 1999
  • Wendell Mayes Jr., Lorna Mellor, Manuel Serrano Rios and Samad Shera are elected as Honorary Presidents
  • Aladin Alwan, James Jackson, Hilary King, Rudolf Korec, Eric Mngola, Z. Skrabalo, Meng Tan and K. Staer-Johanson are elected as Honorary Members
  • Task Force on Congress Development established

2000-2003

  • Sir George Alberti (UK) assumes the Presidency
  • 2000: 17th IDF Congress held in Mexico City, Mexico
  • 2000: First edition of IDF Diabetes Atlas published
  • 2000: Consultative Section on the Diabetic Foot established
  • 50th Anniversary of foundation of IDF  
  • IDF membership increases to 176 national diabetes associations in 136 countries
  • Prof. Jak Jervell and Prof. John Turtle are elected as Honorary Presidents
  • Mr Neil Decker, Mr. Thorbjorn Jagland, Prof. Thomas Johnson, Prof. Michiel Krans, Sir A. McIntyre, Sir K. Ramdanee, Prof. S. Tandhanand and Mr. Ray Williams are elected as Honorary Members
  • The following Task Forces are established: IDF Review, Epidemiology and Prevention, Cardiovascular Disease
  • 2003: IDF Life for a Child Programme established

2003–2006

  • Prof. Pierre Lefèbvre (Belgium) assumes the Presidency
  • 2003: 18th IDF Congress held in Paris, France
  • 2003: Second edition of the IDF Diabetes Atlas published
  • IDF Executive Office assumes responsibility for the organisation of the IDF Congress
  • 2006: United Nations Resolution 61/225 ("World Diabetes Day") passed in December
  • The blue circle is introduced as the global symbol of diabetes
  • Ms. Maria de Alva elected as Honorary President
  • The following Task Forces are established: Diabetes awareness, Insurance, Position Statements

2006–2009

  • Prof. Martin Silink (Australia) assumes the Presidency
  • 2006: 19th IDF Congress held in Cape Town, South Africa
  • 2006: Third edition of the IDF Diabetes Atlas published
  • The blue circle becomes the official logo of World Diabetes Day and the global symbol for diabetes awareness
  • The first United Nations World Diabetes Day is marked in New York in November 2007
  • For the first time, landmank buildings and monuments around the world are lit in blue for diabetes awareness in November
  • Diabetes Research and Clinical Practice (DCRP) becomes the official journal of IDF in 2009
  • 2008: IDF appoints first Chief Executive Officer (CEO)
  • Sir George Alberti is elected as Honorary President
  • Task Force on National Diabetes Policy and Action established in 2007
  • 2008: first IDF Centres of Education designated

2009–2012

  • Prof. Jean-Claude Mbanya (Cameroon) assumes the Presidency
  • 2009: 20th IDF Congress held in Montreal, Canada
  • 2009: Fourth edition of the IDF Diabetes Atlas published
  • 2009: IDF is one of the founding members of the NCD Alliance
  • 2011: 21st IDF Congress held in Dubai, UAE
  • 2011: Fifth edition of IDF Diabetes Atlas published
  • IDF plays a leading role in the first UN High Level Meeting on NCDs, held in September 2011
  • It is decided to hold the IDF Congress every two years
  • The following Task Forces are established: Global Advocacy, Science
  • Prof. Paul Zimmet is elected as Honorary President
  • Prof. Linda Simeniero, Prof. Azad Khan and Mr. Brian are elected as Honorary Members

2012–2015

  • Sir Michael Hirst (UK) assumes the Presidency
  • 2013: 22nd IDF Congress is held in Melbourne, Australia
  • 2013: sixth edition of IDF Diabetes Atlas published
  • 2013: WHO voluntary targets on NCDs agreed
  • Establishment of IDF Young Leaders in Diabetes programme and IDF Parliamentarians for Diabetes Global Network (PGDN)
  • 2014: Second UN High Level Meeting on NCDs held in New York
  • 2015: 23rd IDF Congress is held in Vancouver, Canada
  • 2015: Seventh edition of the IDF Diabetes Atlas published
  • Prof. Martin Silink and Prof. Jean-Claude Mbanya are elected as Honorary Presidents

2015-2017

  • Prof. Shaukat Sadikot (India) assumes the presidency
  • IDF membership increases to over 230 national diabetes associations in more than 160 countries
  • 2016: Online IDF School of Diabetes established
  • 2016: Establishment of IDF Blue Circle Voices network
  • Designation of IDF Centres of Excellence in Diabetes Care
  • IDF Disaster Management Response Plan developed
  • 2017: Eighth edition of IDF Diabetes Atlas published
  • 2017: 23rd IDF Congress held in Abu Dhabi, UAE

 

© 2019 International Diabetes Federation Disclaimer